Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal


Suchbegriffe: PROSTATIC NEOPLASMS - DIAGNOSIS , . Treffer: 30


Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583 Doi: 10.1038/s41391-018-0068-3
Web of Science PubMed FullText FullText_MUG



Kaufmann, S; Mischinger, J; Amend, B; Rausch, S; Adam, M; Scharpf, M; Fend, F; Kramer, U; Notohamiprodjo, M; Nikolaou, K; Stenzl, A; Bedke, J; Kruck, S First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.
World J Urol. 2017; 35(7):1023-1029 Doi: 10.1007/s00345-016-1970-8
Web of Science PubMed FullText FullText_MUG


Smolle, MA; Bauernhofer, T; Pummer, K; Calin, GA; Pichler, M Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Int J Mol Sci. 2017; 18(2): Doi: 10.3390/ijms18020473 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155 Doi: 10.1007/978-3-319-42044-8_28
Web of Science PubMed FullText FullText_MUG


Varma, M; Egevad, L; Algaba, F; Berney, D; Bubendorf, L; Camparo, P; Comperat, E; Erbersdobler, A; Griffiths, D; Grobholz, R; Haitel, A; Hulsbergen-van de Kaa, C; Langner, C; Loftus, B; Lopez-Beltran, A; Mayer, N; Nesi, G; Oliveira, P; Oxley, J; Rioux-Leclercq, N; Seitz, G; Shanks, J; Kristiansen, G Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.
J Clin Pathol. 2016; 69(10):852-857 Doi: 10.1136/jclinpath-2016-203658
Web of Science PubMed FullText FullText_MUG



Augustin, H; Mayerhofer, K; Seles, M; Pummer, K Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int. 2015; 95(2):125-131 Doi: 10.1159/000371895 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Dahlhaus, A; Semlitsch, T; Jeitler, K; Horvath, K; Siebenhofer, A Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
Fam Pract. 2015; 32(5):483-491 Doi: 10.1093/fampra/cmv053 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Gerger, A; Pichler, M Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
World J Urol. 2015; 33(11):1661-1667 Doi: 10.1007/s00345-015-1494-7
Web of Science PubMed FullText FullText_MUG



Ponholzer, A; Trubel, S; Schramek, P; Wimpissinger, F; Feichtinger, H; Springer, C; Wehrberger, C; Fischereder, K; Pummer, K; Martini, T; Mayr, R; Pycha, A; Madersbacher, S Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study.
World J Urol. 2014; 32(4):911-916 Doi: 10.1007/s00345-014-1252-2
Web of Science PubMed FullText FullText_MUG


Pummer, K; Rieken, M; Augustin, H; Gutschi, T; Shariat, SF Innovations in diagnostic imaging of localized prostate cancer.
World J Urol. 2014; 32(4):881-890 Doi: 10.1007/s00345-013-1172-6
Web of Science PubMed FullText FullText_MUG



Hansen, J; Auprich, M; Ahyai, SA; de, la, Taille, A; van, Poppel, H; Marberger, M; Stenzl, A; Mulders, PF; Huland, H; Fisch, M; Abbou, CC; Schalken, JA; Fradet, Y; Marks, LS; Ellis, W; Partin, AW; Pummer, K; Graefen, M; Haese, A; Walz, J; Briganti, A; Shariat, SF; Chun, FK Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
Eur Urol. 2013; 63(2):201-9 Doi: 10.1016/j.eururo.2012.07.030
Web of Science PubMed FullText FullText_MUG



Lee, DJ; Cha, EK; Dubin, JM; Beltran, H; Chromecki, TF; Fajkovic, H; Scherr, DS; Tagawa, ST; Shariat, SF Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
BJU Int. 2012; 109(7): 968-985. Doi: 10.1111/j.1464-410X.2011.10643.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Auprich, M; Bjartell, A; Chun, FK; de la Taille, A; Freedland, SJ; Haese, A; Schalken, J; Stenzl, A; Tombal, B; van der Poel, H Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Eur Urol. 2011; 60(5):1045-1054 Doi: 10.1016/j.eururo.2011.08.003
Web of Science PubMed FullText FullText_MUG Google Scholar


Auprich, M; Chun, FK; Ward, JF; Pummer, K; Babaian, R; Augustin, H; Luger, F; Gutschi, S; Budäus, L; Fisch, M; Huland, H; Graefen, M; Haese, A Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
Eur Urol. 2011; 59(1):96-105 Doi: 10.1016/j.eururo.2010.10.024
Web of Science PubMed FullText FullText_MUG Google Scholar



Fuchsjäger, M; Akin, O; Shukla-Dave, A; Pucar, D; Hricak, H The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.
Clin Adv Hematol Oncol. 2009; 7(3):193-202
PubMed Google Scholar


Fuchsjager, MH; Shukla-Dave, A; Hricak, H; Wang, L; Touijer, K; Donohue, JF; Eastham, JA; Kattan, MW Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy
BJU INT. 2009; 104(3): 315-320. Doi: 10.1111/j.1464-410X.2009.08406.x
Web of Science PubMed FullText FullText_MUG Google Scholar



Bhojani, N; Perrotte, P; Hutterer, G; Suardi, N; Jeldres, C; Shariat, SF; Capitanio, U; Arjane, P; Widmer, H; Benard, F; Peloquin, F; Montorsi, F; Karakiewicz, P Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
J Sex Med. 2008; 5(9): 2141-2151. Doi: 10.1111/j.1743-6109.2008.00811.x
Web of Science PubMed FullText FullText_MUG


Fuchsjager, M; Shukla-Dave, A; Akin, O; Barentsz, J; Hricak, H Prostate cancer imaging
Acta Radiol. 2008; 49(1):107-120 Doi: 10.1080/02841850701545821
Web of Science PubMed FullText FullText_MUG Google Scholar


Vener, T; Derecho, C; Baden, J; Wang, H; Rajpurohit, Y; Skelton, J; Mehrotra, J; Varde, S; Chowdary, D; Stallings, W; Leibovich, B; Robin, H; Pelzer, A; Schäfer, G; Auprich, M; Mannweiler, S; Amersdorfer, P; Mazumder, A Development of a multiplexed urine assay for prostate cancer diagnosis.
Clin Chem. 2008; 54(5): 874-882. Doi: 10.1373/clinchem.2007.094912 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Karakiewicz, PI; Hutterer, GC Predicting outcomes in patients with urologic cancers.
Curr Opin Support Palliat Care. 2007; 1(3): 153-168. Doi: 10.1097/SPC.0b013e3282f125ec
PubMed FullText FullText_MUG


Pummer, K; Stettner, H; Augustin, H; Zigeuner, R; Habermann, H; Schips, L; Riedler, I; Trummer, H; Lipsky, K; Williams, SB The use of body mass index to predict pathological stage in patients with clinically localized prostate cancer.
Onkologie. 2007; 30(10): 489-494. Doi: 10.1159/0000106096
Web of Science PubMed FullText FullText_MUG



Augustin, H; Freibauer, C; Bayer, L; Lunglmayr, G; Tschurlovich, F; Kuber, W; Pummer, K Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression.
Prostate Cancer Prostatic Dis. 2006; 9(3):279-283 Doi: 10.1038/sj.pcan.4500883 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG



Hammerer, PG; Augustin, H; Blonski, J; Graefen, M; Haese, A; Erbersdobler, A; Daghofer, F; Huland, H Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system
UROLOGE A. 2004; 43(3): 307-312. Doi: 10.1007/s00120-004-0531-8
Web of Science PubMed FullText FullText_MUG


Herrmann, W; Stöckle, M; Sand-Hill, M; Hübner, U; Herrmann, M; Obeid, R; Wullich, B; Loch, T; Geisel, J The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen.
Clin Chem Lab Med. 2004; 42(9):1051-1057 Doi: 10.1515/CCLM.2004.211
Web of Science PubMed FullText FullText_MUG



Graefen, M; Augustin, H; Karakiewicz, PI; Hammerer, PG; Haese, A; Palisaar, J; Blonski, J; Fernandez, S; Erbersdobler, A; Huland, H Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.
EUR UROL. 2003; 43(1): 6-10. Doi: 10.1016%2FS0302-2838%2802%2900497-9
Web of Science PubMed FullText FullText_MUG


Zigeuner, RE; Lipsky, K; Riedler, I; Auprich, M; Schips, L; Salfellner, M; Pummer, K; Hubmer, G Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients.
Urology. 2003; 62(3):451-455 Doi: 10.1016%2FS0090-4295%2803%2900459-X
Web of Science PubMed FullText FullText_MUG Google Scholar



Solakoglu, O; Maierhofer, C; Lahr, G; Breit, E; Scheunemann, P; Heumos, I; Pichlmeier, U; Schlimok, G; Oberneder, R; Kollermann, MW; Kollermann, J; Speicher, MR; Pantel, K Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors.
Proc Natl Acad Sci U S A. 2002; 99(4):2246-2251 Doi: 10.1073/pnas.042372199 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar



Djavan, B; Bursa, B; Seitz, C; Soeregi, G; Remzi, M; Basharkhah, A; Wolfram, R; Marberger, M Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection.
Urology. 1999; 54(4):603-606 Doi: 10.1016/s0090-4295(99)00280-0
Web of Science PubMed FullText FullText_MUG



Fotter, R; Sager, WD; Justich, E; zur Nedden, D Importance of computer tomography in paediatric diagnostics of abdominal and pelvic tumours (author's transly
Rontgenblatter. 1980; 33(3): 156-162.



Fotter, R; Sager, WD CT of the pelvis and abdomen during childhood (author's transl)
Rofo. 1979; 131(5): 476-479.


© Med Uni Graz Impressum